CYTOKINETICS INCORPOR
55.84
07-十一月-24 14:59:59
15 分钟延时
股票
+0.34
+0.61%
今日范围
54.63 - 57.48
ISIN
N/A
来源
NASDAQ
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 4月 2023 15:00:00 条件 Nasdaq GlobeNewswire
-
Cytokinetics Announces COURAGE-ALS Met Criteria for Futility at Second Interim Analysis
31 3月 2023 06:30:00 条件 Nasdaq GlobeNewswire
-
Cytokinetics Releases Inaugural Corporate Responsibility Report
27 3月 2023 06:30:00 条件 Nasdaq GlobeNewswire
-
Cytokinetics to Participate in Upcoming Investor Conferences
06 3月 2023 15:00:00 条件 Nasdaq GlobeNewswire
-
04 3月 2023 09:00:00 条件 Nasdaq GlobeNewswire
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 3月 2023 15:00:00 条件 Nasdaq GlobeNewswire
-
Cytokinetics Reports Fourth Quarter 2022 Financial Results
01 3月 2023 15:00:00 条件 Nasdaq GlobeNewswire
-
28 2月 2023 16:31:51 条件 Nasdaq GlobeNewswire
-
24 2月 2023 15:00:00 条件 Nasdaq GlobeNewswire
-
Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day
22 2月 2023 06:30:00 条件 Nasdaq GlobeNewswire
-
Cytokinetics to Announce Fourth Quarter Results on March 1, 2023
15 2月 2023 15:00:00 条件 Nasdaq GlobeNewswire
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 2月 2023 15:00:00 条件 Nasdaq GlobeNewswire
-
Cytokinetics Announces Recipients of Its Fifth Annual Communications Grant Program
30 1月 2023 06:30:00 条件 Nasdaq GlobeNewswire
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 1月 2023 15:00:00 条件 Nasdaq GlobeNewswire
-
Cytokinetics to Participate in the 41st Annual J.P. Morgan Healthcare Conference
03 1月 2023 15:00:00 条件 Nasdaq GlobeNewswire
-
Cytokinetics Announces Outcome of FDA Advisory Committee Vote On Omecamtiv Mecarbil
13 12月 2022 16:45:52 条件 Nasdaq GlobeNewswire
-
Cytokinetics Stock Trading Halted Today
13 12月 2022 06:02:16 条件 Nasdaq GlobeNewswire
-
09 12月 2022 07:59:34 条件 Nasdaq GlobeNewswire
-
Cytokinetics Presents Data at the Virtual 33rd International Symposium on ALS/MND
08 12月 2022 06:30:00 条件 Nasdaq GlobeNewswire
-
Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-3828136
07 12月 2022 06:30:00 条件 Nasdaq GlobeNewswire